Are Weight-Loss Drugs a Game-Changer? | Harvest Market Minutes: Episode 1
Harvest ETFs Chief Investment Officer and Portfolio Manager Paul MacDonald joins Harvest Market Minutes to explain why the…
Ride the ‘innovation wave’ with health care and tech investments
Technology stocks with even the subtlest hint of an edge in artificial intelligence (AI) have received intense attention among investors of late.
All else being equal: Making the case for equal-weight ETFs
In an equal-weight strategy, such as the one employed by the Invesco S&P 500 Equal Weight Index ETF, the mightiest names are cut down to size.
Want to boost investment income and diversification? Consider dividend ETFs
Investors are often focused on generating passive income with sources ranging from GICs to rental properties….
Six health care stock picks to play defence in times of market volatility
September and October are historically bad months for the stock markets, but U.S. health care equities can be a prescription to help soothe stomach-churning volatility.
Weight loss drugs Ozempic, Wegovy may be right for investors
Breakthroughs in the effectiveness of a class of medicines designed to treat diabetes have become the most talked about drug developments…
How to invest in the hype around weight loss drugs targeting diabetes and obesity
Globe & Mail features HHL – Harvest Healthcare Leaders Income ETF in article on pet treatment companies…
5 Best Travel ETFs In Canada (2023)
Targeting travel and tourism through a travel ETF can pay off handsomely if activity continues to pick up and exceed 2019 levels…
Obesity Drugs and ETF Investing
Harvest ETFs Chief Investment Officer & Portfolio Manager Paul MacDonald explains how treatments like Ozempic are changing…